"We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but ...

The following is a summary of “Microcystoid macular edema in epiretinal membrane: not a retrograde maculopathy,” published in ...

Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema (DME) ...

ProstaVive is a dietary supplement specifically formulated to promote prostate health and improve bladder control. According ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

XOMA Royalty Corporation's portfolio includes riskier assets, impacting its stability. Find out why XOMA stock’s high-risk ...

Heart disease is often associated with the heart and arteries, but its effects extend far beyond the cardiovascular system.

Enrollment in DURAVYU Phase 3 wet AMD clinical trials exceeding expectations with the LUGANO trial one-third enrolled and the LUCIA trial ...

Research shows that nearly one-third of seniors with diabetes experience some level of retinopathy. Another vision-related ...

4D Molecular Therapeutics is axing two clinical programs and cutting off funds for three other assets, with resources to be ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 in the open-access journal PLOS Biology by Beata ... Age-related macular ...